| # | Drug | Count |
|---|---|---|
| 0 | AMLODIPINE | 2 |
| 1 | EVOLOCUMAB | 2 |
| 2 | PANTOPRAZOLE | 2 |
| 3 | 0XYGEN | 1 |
| 4 | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL | 1 |
| 5 | ALENDRONATE SODIUM | 1 |
| 6 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 |
| 7 | BUPROPION | 1 |
| 8 | CLONIDINE | 1 |
| 9 | ETONOGESTREL AND ETHINYL ESTRADIOL | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 | 0.0004 |
| 1 | NITRIC OXIDE | 1 | 0.0002 |
| 2 | HUMAN INSULIN | 1 | 0.0001 |
| 3 | TELMISARTAN | 1 | 0.0001 |
| 4 | ETONOGESTREL AND ETHINYL ESTRADIOL | 1 | 0.0000 |
| 5 | SUCRALFATE | 1 | 0.0000 |
| 6 | INSULIN HUMAN | 1 | 0.0000 |
| 7 | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL | 1 | 0.0000 |
| 8 | 0XYGEN | 1 | 0.0000 |
| 9 | OXYGEN | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Calcium Channel Blocker [EPC] | 2 |
| 1 | Dihydropyridine Calcium Channel Blocker [EPC] | 2 |
| 2 | Insulin Analog [EPC] | 2 |
| 3 | PCSK9 Inhibitor [EPC] | 2 |
| 4 | Aluminum Complex [EPC] | 1 |
| 5 | Angiotensin 2 Receptor Blocker [EPC] | 1 |
| 6 | Central alpha-2 Adrenergic Agonist [EPC] | 1 |
| 7 | Estrogen [EPC] | 1 |
| 8 | Insulin [EPC] | 1 |
| 9 | Loop Diuretic [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | PCSK9 Inhibitor [EPC] | 2 | 0.0001 |
| 1 | Aluminum Complex [EPC] | 1 | 0.0000 |
| 2 | Insulin [EPC] | 1 | 0.0000 |
| 3 | Central alpha-2 Adrenergic Agonist [EPC] | 1 | 0.0000 |
| 4 | Dihydropyridine Calcium Channel Blocker [EPC] | 2 | 0.0000 |
| 5 | Estrogen [EPC] | 1 | 0.0000 |
| 6 | Insulin Analog [EPC] | 2 | 0.0000 |
| 7 | Progestin [EPC] | 1 | 0.0000 |
| 8 | Vitamin D [EPC] | 1 | 0.0000 |
| 9 | Angiotensin 2 Receptor Blocker [EPC] | 1 | 0.0000 |